SKIP TO CONTENT
Register now to join The Acta Group (Acta®) for “EU and UK REACH Developments and Compliance Priorities,” a complimentary webinar examining recent developments under European Union (EU) Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and United Kingdom (UK) REACH and their practical implications for companies operating in European Markets. Although EU REACH and UK REACH remain broadly similar in structure, regulatory developments in both jurisdictions continue to shape compliance obligations, registration strategies, and market access considerations. It is vital for companies operating in European markets to understand not only what is changing, but also how these changes may affect their compliance planning and regulatory responsibilities.
During this webinar, professionals from Acta’s UK and EU offices will provide insight into the latest developments affecting EU REACH implementation, including the European Chemicals Agency’s (ECHA) emerging compliance and enforcement priorities. The program will review recent developments under the UK REACH Alternative Transitional Registration Model (ATRm) and give attendees several practical examples of how companies are ensuring compliance in the UK. The presenters will also use case studies to illustrate specific scenarios in which registration or notification obligations may not be readily apparent when considering EU REACH and UK REACH alone, reflecting jurisdiction-specific requirements and regulatory nuances.
Topics Covered:
- EU REACH Developments
- REACH implementation reform and evolving regulatory priorities
- Recent enforcement initiatives and compliance check trends
- UK REACH Developments and Practical Compliance
- Current registration deadlines
- The ABCs of UK REACH compliance
- What companies need to do now
- Jurisdictional Chemical Management Nuances
- Case studies examining how the territorial scope of EU REACH shapes global compliance planning
Speakers:
Christine M. Palermo, Ph.D., DABT, Director of Regulatory Sciences, Acta, provides clients with global strategy in chemical regulatory compliance, risk assessment, and product stewardship, assisting clients with commercializing new products and expanding markets for existing product portfolios. Dr. Palermo deploys the extensive U.S. domestic and international experience she gained as a regulatory sciences principal and leader of global toxicology for ExxonMobil (EM) Biomedical Sciences to advise Acta clients regarding ongoing and anticipated regulatory risk management in the United States, the EU, and Asia for new and existing chemicals and chemical products, including those subject to heavy regulatory scrutiny.
Emma Louise Jackson, Manager, UK REACH, Acta, is distinguished by more than a decade of experience in regulatory environments, assisting clients with achieving regulatory compliance in the UK, the EU, the Americas, and Asia. She offers expertise in worldwide chemical notifications, data analysis, preparing test plans, and managing to completion large and complex compliance projects cost-effectively and harmoniously across multiple jurisdictions. Her focus is on compliance for industrial chemicals and chemical products.
Max L. Moseley, MSc, Regulatory Scientist, Acta, assists clients in the UK, the EU, and worldwide with global chemical regulatory compliance while keeping a keen focus on attendant business impacts. Within the REACH framework, he concentrates on the full spectrum of support services for co-registrants and lead registrants, including compiling and submitting International Uniform Chemical Information Database (IUCLID) dossiers, performing data gap assessments, authoring robust study summaries (RSS), completing quantitative structure-activity relationship (QSAR) assessments, and designing integrated testing strategies.
Lynn L. Bergeson, President, Acta, has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the REACH regulation, the Food Quality Protection Act (FQPA), and other emerging transformative technologies. Ms. Bergeson’s peerless mastery of the complex interplay between chemical innovation, regulatory oversight, policy making, and product commercialization, and her decades of experience as an entrepreneur and business owner, allow her to develop client-focused and business-sensitive strategies whether advocating before the U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug Administration (FDA), U.S. state regulatory agencies, or other governance and standard-setting bodies.
Acta is a global scientific and regulatory consulting firm that assists companies making or using chemicals or chemical products with strategic commercialization planning and complex product registration and compliance matters in North America, South America, Europe, the Middle East, and Asia.
With offices in the United States, UK, and EU, and with a highly experienced staff that has actively assessed REACH and its implications since its inception, Acta is uniquely well-suited to assist innovators to monetize their creations and to guide new and existing registrants in complex regulatory, policy, and commercial challenges.